SMITHS Grp PLC/S (OTCMKTS:SMGZY) was downgraded by equities researchers at Royal Bank of Canada from an “outperform” rating to an “underperform” rating in a report issued on Tuesday.

A number of other research analysts also recently weighed in on SMGZY. Goldman Sachs Group reissued a “neutral” rating on shares of SMITHS Grp PLC/S in a research note on Thursday, October 4th. JPMorgan Chase & Co. reissued a “neutral” rating on shares of SMITHS Grp PLC/S in a research note on Friday, September 21st. Two research analysts have rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company. SMITHS Grp PLC/S currently has a consensus rating of “Hold” and a consensus target price of $27.00.

Shares of SMITHS Grp PLC/S stock traded down $0.53 during trading on Tuesday, hitting $17.61. 8,704 shares of the stock traded hands, compared to its average volume of 77,217. The firm has a market cap of $7.20 billion, a price-to-earnings ratio of 14.55, a P/E/G ratio of 1.95 and a beta of 1.01. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.04 and a quick ratio of 1.56. SMITHS Grp PLC/S has a twelve month low of $16.26 and a twelve month high of $24.42.


Smiths Group plc operates as a technology company severing the medical technology, security and defense, general industrial, oil and gas, and space and commercial aerospace markets worldwide. The company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, and Flex-Tek.

Featured Story: Market Capitalization

Analyst Recommendations for SMITHS Grp PLC/S (OTCMKTS:SMGZY)

Receive News & Ratings for SMITHS Grp PLC/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SMITHS Grp PLC/S and related companies with's FREE daily email newsletter.